Viatris Inc

Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020. The name of the corporation comes from the Latin words via, meaning path, and tris, which means three, referring to the path to three main objectives the corporation set: expanding access to medicines, meeting patient needs through innovation, and earning the trust of the healthcare community. Viatris ranked 254th on the 2021 Fortune 500 rankings of the largest United States corporations based on its 2020 total revenue.

VTRS

Financials

Viatris Inc

Noticias

AMRX: 3 Growth Drivers Behind Amneal's 2026 Outlook

Is AMRX Stock Undervalued? Sales Multiple, Target, Upside

Here's How AMRX Is Tapping GLP-1 Demand Through Manufacturing

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yie

Viatris Inc. (VTRS) Discusses Long-Term Growth Outlook and Portfolio Strategy Across Generics, Established Brands and Innovative Medicines Transcript

Barclays eleva el precio objetivo de Viatris por potencial de cartera

Viatris obtiene aprobación en Japón para Effexor contra ansiedad

24 Safer Buys From 10 Years Of Dogcatcher Digging

Theravance's Q4 Earnings and Revenues Miss Estimates

Viatris: Is It A Credible Turnaround Or Overly Optimistic 2030 Plan?

Micron’s stock is spectacularly cheap, as these numbers show

Viatris establece objetivos de crecimiento de ingresos hasta 2030